US Stock MarketDetailed Quotes
LBPWQ 4D PHARMA PLC C/WTS 22/03/2026 (TO PUR COM)
- 0.000100
- 0.0000000.00%
15min DelayClose Oct 29 16:00 ET
0Market Cap0.00P/E (TTM)
0.000000High0.000000Low0Volume0.000000Open0.000100Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)0Shares0.00140052wk High0.00P/B0Float Cap0.00000152wk Low--Dividend TTM0Shs Float0.040000Historical High--Div YieldTTM0.00%Amplitude0.000001Historical Low--Avg Price1Lot Size
About 4D PHARMA PLC C/WTS 22/03/2026 (TO PUR COM) Company
4D Pharma Plc is a pharmaceutical company, which engages in the development of live bio therapeutics. It focuses on the research of Microbiome, MicroRx, and MicroDx its proprietary platforms for the discovery of novel live bio therapeutics and the development of its pipeline. The company was founded by Duncan Joseph Peyton on January 10, 2014 and is headquartered in Leeds, the United Kingdom.
Company Profile
SymbolLBPWQ
Company Name4D PHARMA PLC C/WTS 22/03/2026 (TO PUR COM)
Listing DateMar 22, 2021
Founded2014
CEOMr. Duncan Joseph Peyton
MarketPink Market
Employees88
Fiscal Year Ends12-31
Address9 Bond Court,5th Floor
CityLeeds
ProvinceYorkshire
CountryUnited Kingdom of Great Britain and Northern Ireland (the)
Zip CodeLS1 2JZ
Phone44-113-895-0130
Websitehttp://www.4dpharmaplc.com
Company Executives
- Name
- Position
- Salary
- Duncan Joseph Peyton
- Chief Executive Officer and Director
- --
- Dr. Alexander James Stevenson
- Chief Scientific Officer and Director
- --
- John Doyle
- Chief Financial Officer
- --
- Professor Axel Gaston Glasmacher
- Non-Executive Chairman of the Board
- --
- Paul Victor Maier
- Independent Director
- --
- Dr. Edgardo Baracchini,PhD
- Independent Director
- --
- Dr. Katrin Juliane Rupalla, PhD
- Independent Director
- --
- Dr. Alexander Donald Macrae
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data